​

Funding Round

Series B - SpringWorks Therapeutics

Series B - SpringWorks Therapeutics

Investment Firm

Overview

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Announced Date

Apr 01, 2019

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

10

Investor Name
Participant InvestorArrowMark Partners
Participant InvestorHBM Healthcare Investments
Participant InvestorGlaxoSmithKline
Participant InvestorOrbiMed
Participant InvestorBain Capital

Round Details and Background

SpringWorks Therapeutics raised $125000000 on 2019-04-01 in Series B

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 07, 2020
Post-IPO Equity - SpringWorks Therapeutics
-287.5M
Sep 07, 2022
Post-IPO Equity - SpringWorks Therapeutics
5-225.0M
Dec 05, 2023
Post-IPO Equity - SpringWorks Therapeutics
-275.0M
Sep 25, 2017
Series A - SpringWorks Therapeutics
5-103.0M

Recent Activity

There is no recent news or activity for this profile.